Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Cancer Research|September 1, 1989
Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibodyA W Tong, J Lee, R M Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2006
Nitrogenase Fe protein: A molybdate/homocitrate insertaseYilin Hu, Mary C Corbett, Aaron W Fay, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2006
FeMo cofactor maturation on NifENYilin Hu, Mary C Corbett, Aaron W Fay, et al.
Clinical Nephrology|March 1, 1995
Effect of recombinant human erythropoietin on hospitalization of hemodialysis patientsD N Churchill, N Muirhead, M Goldstein, et al.
Journal of the American Chemical Society|August 20, 2010
Characterization of isolated nitrogenase FeVcoAaron W Fay, Michael A Blank, Chi Chung Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2005
Nitrogenase reactivity with P-cluster variantsYilin Hu, Mary C Corbett, Aaron W Fay, et al.
Journal of the American Society of Nephrology : JASN|April 1, 1994
Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietinD N Churchill, N Muirhead, M Goldstein, et al.
Journal of the American Chemical Society|April 2, 2009
VTVH-MCD study of the Delta nifB Delta nifZ MoFe protein from Azotobacter vinelandiiMarcia S Cotton, Kresimir Rupnik, Robyn B Broach, et al.
Human Immunology|May 1, 1994
Characterization of skin-infiltrating cells during acute graft-versus-host disease following bone marrow transplantation using unrelated marrow donorsA Nikaein, T Poole, R Fishbeck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 17, 1999
Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantationD Przepiorka, R A Nash, J R Wingard, et al.
Pageof 15